Terms & Conditions

By using our Website you agree that you have read these terms and conditions and that you agree to them. These terms and conditions and your use of this Website are governed by and construed in accordance with the laws of England and Wales and subject to the exclusive jurisdiction of the English courts. If you do not agree to these terms and conditions you are not authorised to use this Website.

You may print off and keep a copy of these terms & condition. They are a legal agreement between you and Shinfield Pharmaceuticals Ltd and can only be reviewed or revised by our own express consent. We reserve the right to change the terms at our discretion by changing them on the Website.

As stated on our products page, any information about our products and services provided on the Website is for general information only, and are not in any way intended to replace the advice of a relevant medical practitioner

Pharmaceuticals News

Aug 28, 2014 FDA Approves Conversion of SolirisĀ® (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque auctor aliquam lectus eget venenatis. Nam fermentum est quam, sit amet porttitor quam blandit nec.

Morbi condimentum felis felis, in auctor sapien commodo ac. Donec ege

More News
For General
Enquiries Call Us on + 44 (0) 1189 653845